Sequana Therapeutics, Inc.
Records under this name other than patents Sequana Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Sequana Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,100,058 | Gap12 genes and their uses Lapsed on the fee record Ended Aug 8, 2008 · USPTO record | Lapsed on the fee record | Ended Aug 8, 2008 | USPTO record |
| US 6,069,010 | High throughput gene inactivation with large scale gene targeting Formerly held Lapsed on the fee record Ended May 30, 2004 · USPTO record | Lapsed on the fee record | Ended May 30, 2004 | USPTO record |
| US 5,686,598 | Genes associated with retinal dystrophies Formerly held Term ended Term ended no later than Nov 11, 2017 · Low confidence | Term ended | Term ended no later than Nov 11, 2017 | Low confidence |
| US 5,705,380 | Identification of a gene encoding TULP2, a retina specific protein Formerly held Term ended Term ended no later than Jan 6, 2018 · Low confidence | Term ended | Term ended no later than Jan 6, 2018 | Low confidence |
| US 5,714,329 | Methods for the diagnosis of a genetic predisposition to cancer associated with variant CDK4 allele Formerly held Term ended Term ended no later than Feb 3, 2018 · Low confidence | Term ended | Term ended no later than Feb 3, 2018 | Low confidence |
| US 5,770,432 | Obesity associated genes Formerly held Term ended Term ended no later than Jun 23, 2018 · Low confidence | Term ended | Term ended no later than Jun 23, 2018 | Low confidence |
| US 5,776,762 | Obesity associated genes Formerly held Term ended Term ended no later than Jul 7, 2018 · Low confidence | Term ended | Term ended no later than Jul 7, 2018 | Low confidence |